Elliott Israel
#148,230
Most Influential Person Now
Elliott Israel's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Elliott Israel Influential?
(Suggest an Edit or Addition)Elliott Israel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. (2010) (1822)
- Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. (2007) (876)
- Meta-analysis of Genome-wide Association Studies of Asthma In Ethnically Diverse North American Populations (2011) (772)
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial (2004) (618)
- Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. (2010) (605)
- Significant variability in response to inhaled corticosteroids for persistent asthma. (2002) (601)
- Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment (1999) (578)
- The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. (2000) (565)
- Tiotropium bromide step-up therapy for adults with uncontrolled asthma. (2010) (509)
- Treatment of asthma with drugs modifying the leukotriene pathway. (1999) (452)
- IL-17 producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity (2013) (430)
- Correction: Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. (1999) (429)
- Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma (2013) (409)
- Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. (2007) (400)
- The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. (1993) (387)
- The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. (1990) (375)
- A role for the C3a anaphylatoxin receptor in the effector phase of asthma (2000) (373)
- COVID-19–related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids (2020) (346)
- The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma (1993) (344)
- Long-Acting β2-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma: A Randomized Controlled Trial (2001) (343)
- Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. (1996) (342)
- Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness1 (2007) (340)
- Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. (1997) (333)
- Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. (2016) (326)
- Obesity and asthma: an association modified by age of asthma onset. (2011) (319)
- Daily versus as-needed corticosteroids for mild persistent asthma. (2005) (317)
- Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. (1996) (311)
- Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. (2004) (310)
- Severe and Difficult‐to‐Treat Asthma in Adults (2017) (302)
- Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations (2016) (299)
- Active albuterol or placebo, sham acupuncture, or no intervention in asthma. (2011) (292)
- Effects of inhaled glucocorticoids on bone density in premenopausal women. (2001) (290)
- Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. (2008) (286)
- Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. (2001) (282)
- Beyond mortality: future clinical research in acute lung injury. (2010) (271)
- β-Adrenergic Receptor Polymorphisms and Response to Salmeterol (2006) (271)
- Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. (2010) (269)
- Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients (1999) (268)
- Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. (2011) (266)
- Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. (2014) (262)
- Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. (2010) (257)
- Diminished lipoxin biosynthesis in severe asthma. (2005) (244)
- Systemic effect comparisons of six inhaled corticosteroid preparations. (2002) (244)
- Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction (2018) (241)
- Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. (2014) (233)
- Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. (2008) (227)
- Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. (2015) (226)
- Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. (2012) (221)
- The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. (1994) (214)
- Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. (2021) (204)
- Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment (2017) (202)
- Recovery of leukotriene E4 from the urine of patients with airway obstruction. (1992) (199)
- Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. (1996) (197)
- Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial (2009) (192)
- Clinical predictors of health-related quality of life depend on asthma severity. (2001) (192)
- Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. (2005) (191)
- The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. (2007) (187)
- Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age. (2017) (186)
- Airway constriction pattern is a central component of asthma severity: the role of deep inspirations. (2001) (183)
- Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. (2012) (174)
- Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. (2002) (163)
- Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. (2001) (160)
- Airway and lung tissue mechanics in asthma. Effects of albuterol. (1999) (151)
- Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. (2008) (151)
- beta-Adrenergic receptor polymorphisms and response to salmeterol. (2006) (148)
- Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. (2007) (145)
- An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. (2013) (141)
- Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. (2012) (140)
- Antileukotrienes in the Treatment of Asthma (1997) (138)
- Individualized therapy for persistent asthma in young children. (2016) (138)
- KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma (2017) (136)
- Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. (1998) (135)
- A trial of clarithromycin for the treatment of suboptimally controlled asthma. (2010) (135)
- Alternative Macrophage Activation Is Increased in Asthma. (2016) (128)
- Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids (2018) (126)
- Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. (2016) (126)
- Importance of hedgehog interacting protein and other lung function genes in asthma. (2011) (125)
- Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma (2018) (125)
- Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. (2000) (122)
- Alterations of the arginine metabolome in asthma. (2008) (122)
- TSLP polymorphisms are associated with asthma in a sex‐specific fashion (2010) (121)
- Eotaxin and impaired lung function in asthma. (1999) (119)
- Amplification of airway constriction due to liquid filling of airway interstices. (1989) (119)
- Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. (2001) (118)
- Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review (2003) (117)
- Effects of montelukast and beclomethasone on airway function and asthma control. (2002) (116)
- Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy. (2001) (116)
- Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene (2012) (114)
- Effect of Polymorphism of the β2-Adrenergic Receptor on Response to Regular Use of Albuterol in Asthma (2001) (113)
- IL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression (2007) (111)
- Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma (2019) (111)
- Integrating real-life studies in the global therapeutic research framework. (2013) (109)
- Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. (2013) (108)
- Detrimental Effects of Environmental Tobacco Smoke in Relation to Asthma Severity (2011) (108)
- Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. (2001) (107)
- Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations (2018) (103)
- A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis (2018) (98)
- Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. (2014) (98)
- Exhaled breath condensate eicosanoid levels associate with asthma and its severity. (2013) (97)
- Predictors of response to tiotropium versus salmeterol in asthmatic adults. (2013) (96)
- Sleep quality and asthma control and quality of life in non-severe and severe asthma (2012) (94)
- Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus. (2012) (93)
- Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. (1995) (90)
- A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. (2000) (90)
- Quality of dyspnea in bronchoconstriction differs from external resistive loads. (2000) (88)
- Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma. (2019) (84)
- Natural killer T cells in the lungs of patients with asthma. (2009) (83)
- Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. (2019) (82)
- Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma (2017) (81)
- Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity (2011) (81)
- Impact of race on asthma treatment failures in the asthma clinical research network. (2011) (80)
- Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects. (1995) (80)
- Exhaled nitric oxide following repeated spirometry or repeated plethysmography in healthy individuals. (2000) (79)
- Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program. (2013) (78)
- Asthma Is More Severe in Older Adults (2015) (78)
- Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. (2007) (77)
- Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics. (1989) (77)
- Insulin resistance modifies the association between obesity and current asthma in adults (2016) (77)
- Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. (2010) (74)
- Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. (2021) (74)
- Bacterial biogeography of adult airways in atopic asthma (2018) (73)
- HLA‐DQ strikes again: Genome‐wide association study further confirms HLA‐DQ in the diagnosis of asthma among adults (2012) (70)
- Predicting Intermediate Phenotypes in Asthma Using Bronchoalveolar Lavage‐Derived Cytokines (2010) (68)
- Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. (2014) (68)
- Inhaled Albuterol, but Not Intravenous Lidocaine, Protects Against Intubation-induced Bronchoconstriction in Asthma (2000) (67)
- IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. (2007) (67)
- Corticosteroid suppression of lipoxin A4 and leukotriene B4from alveolar macrophages in severe asthma (2010) (66)
- Safety of investigative bronchoscopy in the Severe Asthma Research Program. (2011) (66)
- Natural killer cell–mediated inflammation resolution is disabled in severe asthma (2017) (65)
- Determinants of exhaled breath condensate pH in a large population with asthma. (2011) (65)
- Asthma control with extrafine‐particle hydrofluoroalkane–beclometasone vs. large‐particle chlorofluorocarbon–beclometasone: a real‐world observational study (2011) (65)
- Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency. (2020) (65)
- Effects of allergen challenge on airway epithelial cell gene expression. (2005) (65)
- ALOX5 promoter genotype, asthma severity and LTC4 production by eosinophils (2005) (65)
- Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells (2014) (63)
- Noninvasive Markers of Airway Inflammation in Asthma (2009) (62)
- Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma (2018) (61)
- Mouse allergens in urban elementary schools and homes of children with asthma. (2008) (61)
- Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial. (2021) (60)
- Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. (2015) (57)
- Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. (2019) (54)
- Effects of inhaled fluticasone on upper airway during sleep and wakefulness in asthma: a pilot study. (2014) (53)
- Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma. (2016) (53)
- Variant eotaxin: its effects on the asthma phenotype. (2001) (53)
- 677 The therapeutic effects of MK-571, a potent and selective leukotriene (LT) D4 receptor antagonist, in patients with chronic asthma (1991) (52)
- Impact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012 (2016) (52)
- Relating maximum airway dilation and subsequent reconstriction to reactivity in human lungs. (2004) (50)
- The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation (2018) (49)
- Acetazolamide and furosemide attenuate asthma induced by hyperventilation of cold, dry air. (1992) (49)
- Racial differences in biologic predictors of severe asthma: Data from the Severe Asthma Research Program. (2010) (47)
- Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial. (2014) (47)
- Income is an independent risk factor for worse asthma outcomes (2016) (47)
- How pharmacogenomics will play a role in the management of asthma. (2005) (46)
- Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III. (2016) (45)
- Impact of Age and Sex on Response to Asthma Therapy. (2015) (44)
- Enhancement of plasma levels of biologically active leukotriene B compounds during anaphylaxis in guinea pigs pretreated by indomethacin or by a fish oil-enriched diet. (1986) (43)
- An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. (1997) (42)
- Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma (2015) (41)
- Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. (2006) (41)
- Race is associated with differences in airway inflammation in patients with asthma (2017) (40)
- Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort (2018) (40)
- Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma. (2015) (40)
- Exhaled breath condensates in asthma: diagnostic and therapeutic implications (2010) (40)
- Predicting worsening asthma control following the common cold (2008) (40)
- Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3. (2015) (39)
- Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide. (2013) (38)
- Tracking variations in airway caliber by using total respiratory vs. airway resistance in healthy and asthmatic subjects. (2003) (37)
- Impact of a Soluble Phospholipase A2 Inhibitor on Inhaled Allergen Challenge in Subjects with Asthma (2005) (36)
- The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients. (2012) (36)
- The role of pharmacogenomics in improving the management of asthma. (2010) (35)
- Impact of botanical oils on polyunsaturated fatty acid metabolism and leukotriene generation in mild asthmatics (2013) (33)
- Age-Specific Prevalence of Outdoor and Indoor Aeroallergen Sensitization in Boston (2010) (33)
- Simple Tandem Repeat Polymorphisms in the Neuronal Nitric Oxide Synthase Gene in Different Ethnic Populations (1999) (33)
- Analysis of T-cell activation after bronchial allergen challenge in patients with atopic asthma. (1998) (33)
- Integration of Mouse and Human Genome-Wide Association Data Identifies KCNIP4 as an Asthma Gene (2013) (33)
- The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research. (2001) (32)
- Severe asthma during childhood and adolescence: A longitudinal study. (2019) (32)
- Genetics and the variability of treatment response in asthma. (2005) (32)
- Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-Exacerbated Respiratory Disease: A Prospective Trial. (2019) (32)
- Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD (2014) (31)
- Effects of inhaled glucocorticoids on bone density in premenopausal women (2002) (31)
- Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone. (2013) (31)
- Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids (2017) (31)
- Adam8 Limits the Development of Allergic Airway Inflammation in Mice (2013) (31)
- Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program. (2014) (30)
- Exhaled nitric oxide following leukotriene E(4) and methacholine inhalation in patients with asthma. (2000) (30)
- A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin‐exacerbated respiratory disease (2019) (29)
- Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies. (2017) (29)
- IL-13 Augments Compressive Stress-Induced Tissue Factor Expression in Human Airway Epithelial Cells. (2016) (29)
- Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjects. (2012) (29)
- Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma (2015) (28)
- Obesity's effect on asthma extends to diagnostic criteria (2017) (28)
- Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways. (2020) (28)
- Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma. (2015) (27)
- Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma. (2020) (27)
- Treating mild asthma--when are inhaled steroids indicated? (1994) (25)
- Asthma and Corticosteroid Responses in Childhood and Adult Asthma. (2019) (25)
- Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma. (2017) (25)
- Moderating the inflammation of asthma: inhibiting the production or action of products of the 5-lipoxygenase pathway. (1994) (24)
- Update on reslizumab for eosinophilic asthma (2015) (24)
- Agonist-induced lipoxin A4 generation: Detection by a novel lipoxin A4-ELISA (1993) (24)
- HSD3B1 genotype identifies glucocorticoid responsiveness in severe asthma (2020) (24)
- A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER) (2020) (23)
- ALX receptor ligands define a biochemical endotype for severe asthma. (2017) (23)
- Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program. (2021) (23)
- Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. (1997) (23)
- Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes. (1998) (23)
- The endogenous circadian system worsens asthma at night independent of sleep and other daily behavioral or environmental cycles (2021) (22)
- Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study (2014) (22)
- Atopic asthma: differential activation phenotypes among memory T helper cells (2001) (22)
- Exacerbation-Prone Asthma in the Context of Race and Ancestry in Asthma Clinical Research Network Trials. (2019) (21)
- Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma. (2015) (21)
- Effect of COVID-19 on asthma exacerbation (2021) (21)
- Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A Proposal. (2017) (21)
- ALX receptor ligands define a biochemical endotype for severe asthma. (2018) (20)
- Investigation of the relationship between IL-6 and type 2 biomarkers in severe asthma. (2019) (20)
- A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics. (2011) (20)
- Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease. (2019) (19)
- Update in asthma 2011. (2012) (18)
- How does airway inflammation modulate asthmatic airway constriction? An antigen challenge study. (2003) (18)
- Effect of School Integrated Pest Management or Classroom Air Filter Purifiers on Asthma Symptoms in Students With Active Asthma: A Randomized Clinical Trial. (2021) (18)
- Baseline sputum eosinophil+neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) Cohort. (2020) (18)
- Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. (2019) (18)
- Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands (2016) (18)
- Role of cysteinyl leukotrienes in spontaneous asthmatic responses. (1994) (17)
- PrecISE: Precision Medicine in Severe Asthma An Adaptive Platform Trial with Biomarker Ascertainment. (2021) (16)
- ITGB5 and AGFG1 variants are associated with severity of airway responsiveness (2013) (16)
- Blood Institute Severe Asthma Research Program (2008) (16)
- Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. (2022) (16)
- Subspecialty differences in asthma characteristics and management. (2008) (16)
- Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: results from SARP-3. (2021) (16)
- Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. (2020) (16)
- Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathway. (1995) (15)
- P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. (2013) (14)
- Key observations from the NHLBI Asthma Clinical Research Network (2012) (14)
- Benefits of Airway Androgen Receptor Expression in Human Asthma. (2021) (14)
- Airway narrowing in athletes: a different kettle of fish? (2003) (14)
- Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium (2020) (14)
- Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids. (2017) (13)
- Capsaicin-induced airway obstruction in tracheally perfused guinea pig lungs. (1994) (13)
- Development and Initial Validation of the Asthma Severity Scoring System (ASSESS). (2020) (13)
- Pharmacogenetics of treatment with leukotriene modifiers (2002) (13)
- Daclizumab improves asthma control in patients with refractory asthma (2005) (13)
- Diagnostic yield of bronchoalveolar lavage and bronchoscopic lung biopsy for detection of Pneumocystis carinii. (1996) (12)
- Mucus Plugs Persist in Asthma and Changes in Mucus Plugs Associate with Changes in Airflow Over Time. (2022) (12)
- WAO International Scientific Conference (WISC 2016) Abstracts (2017) (12)
- Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids (2016) (12)
- The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma. (2022) (11)
- Treatment with β blockers in people with COPD (2011) (11)
- Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler (2016) (11)
- Challenges conducting comparative effectiveness research: the Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) experience (2014) (11)
- Clinical Decisions. Treatment of mild persistent asthma. (2007) (10)
- Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma. (2022) (10)
- Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma (2020) (10)
- Differential effects of calcium channel blockers on leukotriene C4- and D4-induced contractions in guinea pig pulmonary parenchymal strips. (1987) (10)
- The effects of a fish-oil-enriched diet on pulmonary mechanics during anaphylaxis. (1985) (9)
- Assessment of therapeutic index of inhaled steroids (2000) (9)
- The effects of an insertion in the 5'UTR of the AMCase on gene expression and pulmonary functions. (2011) (9)
- Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma. (2011) (9)
- The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations (2020) (9)
- Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma (2020) (9)
- Newer therapeutic agents for asthma. (1999) (8)
- Automated patient and medication payment method for clinical trials (2013) (8)
- Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate to Severe Asthma. (2020) (8)
- Plasma IL6 levels, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts (2016) (8)
- Summarizing methacholine challenges in clinical research. (2001) (8)
- Update in asthma 2010. (2011) (8)
- Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study (2021) (7)
- Asthma: a solution to half the puzzle? (1991) (7)
- Adherence to Adding Inhaled Corticosteroids to Rescue Therapy in a Pragmatic Trial with Adults with Asthma- a Pilot Study. (2020) (7)
- Long-acting beta-agonists and inhaled corticosteroids: is the whole greater than the sum of its parts? (2010) (7)
- What doesn't kill may not make you stronger. β-blockers for asthma. (2013) (7)
- Utility of exhaled breath condensates across respiratory diseases. (2012) (7)
- Flexibility and strength training in asthma: A pilot study (2018) (6)
- Inhaled diuretics in asthma: the search for the mechanism of action. (1994) (6)
- Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels: (2014) (6)
- Masitinib Significantly Decreases the Rate of Asthma Exacerbations in Patients with Severe Asthma Uncontrolled by Oral Corticosteroids: A Phase 3 Multicenter Study (2020) (6)
- Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell function. (2016) (6)
- Geography, generalisability, and susceptibility in clinical trials (2021) (6)
- The Combined Effects of Zafirlukast, Prednisone, and Inhaled Budesonide on IL-13 and IFN-γ Secretion (2005) (6)
- Development of a novel digital breath-activated inhaler: Initial particle size characterization and clinical testing. (2018) (6)
- leukotriene B 4 from alveolar macrophages in severe asthma (2010) (6)
- Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial. (2018) (6)
- A randomized, open-label, pragmatic study to assess reliever-triggered inhaled corticosteroid in African American/Black and Hispanic/Latinx adults with asthma: Design and methods of the PREPARE trial (2020) (6)
- Elevated extracellular maspin after mechanical compression in vitro or allergen challenges in vivo. (2019) (5)
- The protective effects of leukotriene modifiers in aspirin-induced asthma. (2000) (5)
- The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years. (2021) (5)
- Effect of KIT Inhibition by Imatinib on Airway Mast Cells in Patients with Severe Refractory Asthma (KIA) (2017) (5)
- Real-world experiences with generating real-world evidence: Case Studies from PCORI's pragmatic clinical Studies program. (2020) (5)
- SAR440340, An Anti-IL-33 Monoclonal Antibody, Demonstrated a Significant Reduction of LOAC Events and Improved Pre-BD FEV1 in Patients with Moderate to Severe Asthma: Results from the Phase 2 Proof of Concept Study (2020) (5)
- ROLE OF 5-LIPOXYGENASE METABOLITES OF ARACHIDONIC ACID IN EXERCISE-INDUCEDASTHMA (1999) (5)
- Low CC16 mRNA Expression Levels in Bronchial Epithelial Cells Are Associated with Asthma Severity. (2022) (5)
- Predictive Model Of Severe Atopic Asthma Phenotypes Using Interleukin 4/13 Pathway Polymorphisms (2011) (5)
- Omalizumab does not induce thrombocytopenia in the treatment of asthma (2003) (5)
- Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. (2023) (4)
- Use of the Asthma Control Questionnaire by the Asthma Clinical Research Network (2011) (4)
- Implementing the guidelines: What do you do when the rubber hits the road? (2020) (4)
- Rethinking the prevalence of exercise-induced bronchoconstriction in patients with asthma. (2013) (4)
- Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial (2020) (4)
- LTC4 production by eosinophils in asthmatic subjects with alternative forms of ALOX-5 core promoter. (2003) (4)
- Food and Drug Administration‐mandated Trials of Long‐Acting &bgr;‐Agonist Safety in Asthma. Bang for the Buck? (2018) (4)
- β-adrenergic receptor genotype and response to salmeterol (2007) (4)
- Mepolizumab as a Steroid-Sparing Treatment in the Churg Strauss Syndrome. (2009) (4)
- The genetics of asthma. (2002) (4)
- Estimated Ventricular Size, Asthma Severity and Exacerbations: The SARP III Cohort. (2019) (3)
- Thymic Stromal Lymphopoietin Controls Prostaglandin D2 Generation in Aspirin-Exacerbated Respiratory Disease (2016) (3)
- Susceptibility to exacerbations in Black adults with asthma (2018) (3)
- Dupilumab Treatment Leads to Clinical Asthma Remission in Patients With Uncontrolled Moderate-to-Severe Asthma With Type 2 Inflammation (2021) (3)
- Nocturnal bilevel positive airway pressure for the treatment of asthma (2019) (3)
- Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. (2019) (3)
- A functional splicing variant associated with decreased asthma risk abolishes the ability of gasdermin B (GSMDB) to induce epithelial cell pyroptosis (2018) (3)
- 66 Levalbuterol is effective in the prevention of cold air induced bronchospasm and des not induce tachyphylaxis in the degree of bronchoprotection (2000) (3)
- Socioeconomic status associates with worse asthma morbidity among Black and Latinx adults. (2022) (3)
- beta-adrenergic receptor genotype and response to salmeterol. (2007) (3)
- Internet‐Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control (2017) (3)
- The Effect of Aging and Menopause on Asthma Severity in Women (2014) (3)
- LTC4 synthase polymorphism modifies efficacy of botanical seed oil combination in asthma (2014) (3)
- Compressive Stress Causes an Unjamming Transition and an Epithelial-Mesenchymal Transition in the Airway Epithelium in Asthma. (2016) (2)
- Evaluation of difficult-to-treat and severe asthma in adults (2019) (2)
- Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine era. (2019) (2)
- Genetic analysis in the Asthma Clinical Research Network. (2001) (2)
- Severe asthma: pragmatic clinical lumping and time for investigational splitting. (2014) (2)
- AIR2 Trial: Execution of a Sham-Controlled Double-Blind Study of a Novel Device for the Treatment of Severe Asthma. (2009) (2)
- Enrollment Update of the Epidemiologic Study of Xolair: Evaluating the Long-Term Safety and Clinical Effectiveness in Patients with Moderate to Severe Asthma (EXCELS) (2006) (2)
- Erratum: The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma (International Archives of Allergy and Immunology (2000) 162 (75-80)) (2012) (2)
- ADRB2 Arg16Gly polymorphism in the LARGE trial – Authors' reply (2010) (2)
- Individual Gene Expression Signatures in Severe Asthmatics Identify Responders and Non-Responders to Imatinib (2019) (2)
- Airway Inflammation, As Detected By Exhaled Nitric Oxide, Predicts Loss Of Bronchoprotection Against Exercise-induced Bronchospasm (EIB) From Long-acting ²-2 Agonists (LABAs) (2010) (2)
- Leukotrienes and rhinitis (2001) (2)
- Nebulizer Use by Black and Latinx Adults with Moderate to Severe Asthma. (2021) (2)
- Extra-fine inhaled corticosteroids are better for asthma control : A systematic review and meta-analysis of observational real-life studies (2018) (2)
- Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 (2016) (2)
- Quantitative CT Characteristics of Cluster Phenotypes in the Severe Asthma Research Program Cohorts. (2022) (2)
- Rare Beta2-Adrenergic Receptor Gene Polymorphisms In Asthma Cases And Controls From The Severe Asthma Research Program (2011) (2)
- KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma - Impact on Airway Remodeling measured by MDCT (2018) (2)
- The asthma Symptom Free Days Questionnaire: how reliable are patient responses? (2018) (1)
- Mechanisms and Treatment of the Diverse Presentations of Acute Wheezing and Asthma. (2021) (1)
- A Ferroptosis-Related Gene Signature Predicts Exacerbation-Prone Asthma (2019) (1)
- 116 Genome-Wide Association Studies of Asthma Indicate Opposite Immunopathogenesis Direction From Autoimmune Diseases (2012) (1)
- Anti-IgE or Anti-IL5: That Is the Question. (2017) (1)
- Biomarkers to Predict Response to ICS and LAMA in Adolescents and Adults with Mild Persistent Asthma. (2021) (1)
- Precision Medicine. Personalizing Guidelines to the Provider as Well as the Patient: Making the Juice Worth the Squeeze. (2015) (1)
- Asthma Step-Down Strategies: Perhaps the Patient Should Decide? (2018) (1)
- Introduction: The rise of the age of individualism—Variability in the pathobiology, response to treatment, and treatment outcomes in asthma (2005) (1)
- Influence of Key Clinical Baseline Characteristics on Benralizumab Response for Patients with Severe, Uncontrolled Asthma and Moderate Blood Eosinophilia (2020) (1)
- Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy (2013) (1)
- Leukotrienes and immediate hypersensitivity responses. (1985) (1)
- Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size (2017) (1)
- P104 TOTAL NASAL SYMPTOM SCORE IMPROVEMENT WITH BENRALIZUMAB FOR PATIENTS WITH SEVERE, EOSINOPHILIC ASTHMA (2019) (1)
- Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study (2021) (1)
- Effects Of Inhaled Fluticasone Treatment On Upper Airway Collapsibility During Sleep In Asthma Patients (2011) (1)
- 90 – Pharmacogenomics of Asthma Therapies (2014) (1)
- Features of the Bronchial Bacterial Microbiome Associated with Allergy and Mild Allergic Asthma. (2016) (1)
- Arachnoids and asthma: the role of receptors of leukotrienes (1991) (1)
- Reply: "The intrinsic bias of generalizations" and "Far from 'disappointing'". (2014) (1)
- Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist (2016) (1)
- Biologics, Clinical Context, and the Asthmas. (2019) (1)
- Personalizing Precision Medicine. (2020) (1)
- Mitochondrial DNA Variation and Severe Asthma (2019) (1)
- What Patients Can Tell Us About Their Asthma. (2019) (1)
- Step-Up Therapy in Black Patients with Asthma. Reply. (2020) (1)
- Airway Inflammation in Mice Adam8 Limits the Development of Allergic (2013) (0)
- Primary and Secondary Prevention of Asthma: Targeting Viruses, Atopy and the Environment (2017) (0)
- Corticosteroid-Dependent Patient (2019) (0)
- University of Groningen Integration of mouse and human genome-wide association data identifies KCNIP 4 as an asthma gene (2017) (0)
- LEUKOTRIENE RECEPTOR ANTAGONISM AND SYNTHESIS INHIBITION IN CHRONIC STABLEASTHMA (1998) (0)
- Comparative Effectiveness of Extrafine Hydrofluoroalkane Beclometasone (EF HFA-BDP) and Fluticasone Propionate (FP) in Smoking Asthmatic Patients — a Retrospective, Real-Life Observational Study in a UK Primary Care Asthma Population (2013) (0)
- Relationship between genotype at the 5-lipoxygenase core promoter locus and the clinical response to ABT-761 (1999) (0)
- RAPID IMPROVEMENT IN MORNING AND EVENING PEAK EXPIRATORY FLOW IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA TREATED WITH TEZEPELUMAB (2021) (0)
- Erratum: (The Journal of Clinical Investigation (March 1997) 99:5) (1998) (0)
- Nasal polyps and aspirin-sensitive asthma (1997) (0)
- Antagonizing the metabolic hormone cholecystokinin (CCK) and its receptor CCKAR in the lung abolishes obesity-induced airway hyperresponsiveness (2021) (0)
- EFFECT OF TEZEPELUMAB ON LUNG FUNCTION IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN THE PHASE 3 NAVIGATOR STUDY (2021) (0)
- Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands (2016) (0)
- LUNG FUNCTION RESPONSE TO ALBUTEROL-BUDESONIDE VERSUS ALBUTEROL WHEN USED REPETITIVELY OVER 1 AND 4 WEEKS: RESULTS FROM THE DENALI STUDY (2022) (0)
- Sputum Mast Cells and Eosinophils Identify Asthmatics with Lower Lung Function and Proneness to Exacerbations (2018) (0)
- Genetic analyses of chr11p15.5 region identify MUC5AC-MUC5B associated with asthma-related phenotypes. (2023) (0)
- Comparative effectiveness analysis: Extra-fine particle hydrofluoroalkane beclomethasone dipropionate vs fluticasone propionate with spacer in children (2013) (0)
- What Do African American/Black and Hispanic/Latinx Adults Call Their Inhalers? A Report from the PREPARE Study of 1200 Adults with Asthma (2021) (0)
- Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease. (2023) (0)
- Exhaled nitric oxide as an accurate and non-invasive test for asthma (2002) (0)
- Dose-response effect of small particle vs standard size particle inhaled corticosteroids on severe asthma exacerbations by sex (2015) (0)
- 37 CORRELATION BETWEEN HYPERTONIC SALINE PD20 AND METHACHOLINE PC20 IN ASTHMA. (2006) (0)
- ACAID–like human dendritic cells suppress a Th2 response in a chimera asthma model (2004) (0)
- Adherence to Adding ICS to Rescue Therapy in a Pragmatic Trial with Adults with Asthma– a Pilot Study (2018) (0)
- Comparing asthma control assessment using the Asthma Control Test and the Asthma APGAR in African American/Black and Hispanic/Latinx populations. (2023) (0)
- Albuterol-budesonide pressurized metered dose inhaler in patients with mild-to-moderate asthma: results of the DENALI double-blind randomized controlled trial. (2023) (0)
- Barnig Activation in Asthma Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell 4 Lipoxin (2013) (0)
- Seasonal efficacy of mepolizumab in patients with severe eosinophilic asthma – meta-analysis from two phase 3 trials (2020) (0)
- Socioeconomic impact of COVID-19 and willingness to be vaccinated in African American/Black and Hispanic/Latinx adults (2022) (0)
- Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma: A Randomized, Controlled Trial (2009) (0)
- Caribbean Latinx with moderate-severe asthma bear greater asthma morbidity than other Latinx. (2022) (0)
- Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium (2021) (0)
- Severe asthma: the next decade of continuing progress (2019) (0)
- Investigations of a combination of atopic status and age of asthma onset identify asthma subphenotypes. (2023) (0)
- Severe asthma management in adults (2019) (0)
- Novel Treatments for Airway Disease. (2017) (0)
- Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children. (2019) (0)
- Bacterial biogeography of adult airways in atopic asthma (2018) (0)
- Determinants of Breath Condensate pH in a Large Asthma Cohort: pH as a Potential Biomarker for Identifying Asthma Subpopulations. (2009) (0)
- Androgen Metabolism and Severe Asthma: HSD3B1 Genotype Identifies Glucocorticoid Responsiveness (2020) (0)
- Improving Understanding of Stress Exposure in Minority Communities with Asthma: Using Geographic Information Systems (GIS) Data Collection Methods (2014) (0)
- Current and Emerging Biologic Treatments for Asthma (2016) (0)
- The effect of prophylactic palivizumab on recurrent wheezing in children with an atopic family history. (2011) (0)
- HyperresponsivenessDampens Airway Inflammation and Protectin D1 Is Generated in Asthma and (2006) (0)
- Antagonizing cholecystokinin A receptor in the lung attenuates obesity-induced airway hyperresponsiveness (2023) (0)
- The Effects of a Fish-Oil-enriched Diet on Pulmonary Mechanics during Anaphylaxis1–3 (2015) (0)
- Masks and vaccinations prevent Covid19 infection in Black and Latinx adults with moderate-to-severe asthma: survey results from the PREPARE cohort (2023) (0)
- Caregiver treatment preferences for children and adolescents with asthma: a discrete choice experiment (2022) (0)
- Bronchial Mast Cell Markers and Clinical Asthma Severity In Steroid Refractory Asthmatics (2014) (0)
- Dose-Response Effect Of Small-Particle Versus Standard Size Particle Formulations Of Inhaled Corticosteroids On Severe Asthma Exacerbations (2015) (0)
- Monoclonal Therapy in Asthma: Summary of Recent Data and Potential Future Use (2015) (0)
- Longitudinal characteristics of the Severe Asthma Research Program (SARP) clinical clusters (2020) (0)
- a large asthma population Determinants of exhaled breath condensate pH in (2010) (0)
- P213 UNMET MEDICAL NEED ACROSS THE ASTHMA DISEASE SPECTRUM: A US FOCUS GROUP STUDY (2020) (0)
- The Human Gut Microbiomial Metabolite Enterolactone Associates With Better Asthma Control (2020) (0)
- Erratum: Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma (2019) (0)
- Asthma Yardstick (2017) (0)
- Asthma and 5-lipoxygenase (1991) (0)
- Newer therapeutic agents for asthma. (1999) (0)
- Exhaled breath condensate pH is influenced by respiratory droplet dilution (2017) (0)
- Update on Diagnosis for Asthma/COPD Overlap Syndrome (2019) (0)
- Age of Asthma Onset, not Severity, Predicts Environmental Allergy Clusters (2020) (0)
- As-needed inhaled corticosteroids as add-on therapy versus SMART therapy: an evolving understanding of the two approaches in the management of moderate-to-severe asthma (2023) (0)
- Key Issues in Pediatric and Adult Severe Asthma: Staying Grounded as Biologics Take Us to New Heights. (2022) (0)
- What Caused the Screech, Whamity, Bang, and Thump? (2002) (0)
- Association of Non-Coding Region Polymorphisms of ADRB2 with Airway Reactivity in Asthma. (2009) (0)
- Effect Of Nocturnal Bilevel Positive Pressure In Asthma And OSA (2012) (0)
- Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of PATHWAY and NAVIGATOR Studies. (2023) (0)
- Impact of age on extra-fine particle hydrofluoroalkane beclometasone dipropionate versus fluticasone propionate outcomes in asthmatic children (2013) (0)
- The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation (2018) (0)
- Predictors of inhaled corticosteroid taper failure in adults with asthma. (2019) (0)
- ALOX-15 Haplotypes and Association with Asthma. (2009) (0)
- Successfully Reducing Severe Asthma Exacerbations and Improving Asthma Control in a Pragmatic Study in African American/Black (AA/B) and Hispanic/Latinx (H/L) Patients with Moderate-Severe Asthma (PREPARE) (2022) (0)
- Leukotriene Modifiers in the Treatment of Asthma (2003) (0)
- Genetic and non-genetic factors affecting the expression of COVID-19 relevant genes in the large airway epithelium Measures In COPD Study (SPIROMICS), (2020) (0)
- Process and impact as the Journal moves forward. (2013) (0)
- Meta-Analyses Of Genome-Wide Association Studies In Five Asthma Populations Identify Novel Genes Associated With Lung Function (2011) (0)
- Evidence for Upregulation of Innate Immunity Type1 Cytokines in Bronchoalveolar Lavage Fluid from Subjects with Severe Asthma on Daily Oral Corticosteroids in the Severe Asthma Research Program (SARP) (2020) (0)
- Patient Use Of Non-Standard Terms For Asthma Inhalers Is Associated With Worse Asthma Morbidity Outcomes (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Elliott Israel?
Elliott Israel is affiliated with the following schools:
